|
Jan 15
|
Jim Cramer on Abbott Laboratories (ABT): ‘Not Understood Very Well Because They’re Doing Tremendous Stuff When It Comes To Diabetes. People Don’t Seem To Care’
|
|
Jan 15
|
PACB Stock Falls on Preliminary Q4 Sales Miss, 7 Vega Systems Shipped
|
|
Jan 14
|
QuidelOrtho Stock Down Despite Solid Preliminary Q4 Revenues
|
|
Jan 14
|
Returns At Abbott Laboratories (NYSE:ABT) Are On The Way Up
|
|
Jan 4
|
Abbott Laboratories (NYSE:ABT) Could Easily Take On More Debt
|
|
Jan 3
|
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?
|
|
Jan 2
|
3 Dividend Growth Beasts That Have Raised Their Payouts for a Combined 165 Years
|
|
Jan 1
|
Jim Cramer’s Take on Abbott Laboratories (ABT): Bold Predictions for the Future
|
|
Dec 31
|
A Look At The Intrinsic Value Of Abbott Laboratories (NYSE:ABT)
|
|
Dec 30
|
Abbott (ABT) Dips More Than Broader Market: What You Should Know
|
|
Dec 30
|
5 MedTech Stocks That Are Poised to Beat the Market in 2025
|
|
Dec 28
|
Why Is Abbott Laboratories (ABT) Among Diamond Hill Capital’s Top Stock Picks?
|
|
Dec 28
|
2 No-Brainer Healthcare Stocks to Buy With $1,000 Right Now
|
|
Dec 27
|
Growing Biosimilars Business, New Partnerships Support ABT Stock
|
|
Dec 27
|
Abbott Laboratories (NYSE:ABT) is largely controlled by institutional shareholders who own 77% of the company
|
|
Dec 26
|
Is Abbott Stock Worth Buying at a Discounted P/S Valuation?
|
|
Dec 25
|
Abbott, DexCom settlement ‘not a complete surprise,’ says Wells Fargo
|
|
Dec 25
|
DexCom, Abbott agree to settle patent litigation
|
|
Dec 24
|
Glaukos Stock Down Despite NDA Submission of Epioxa to the FDA
|
|
Dec 23
|
Abbott (ABT) Rises Yet Lags Behind Market: Some Facts Worth Knowing
|